DSDave SinghSep 1, 2026New paperautoPaperA first‐in‐human study of CAL101, a monoclonal antibody targeting S100A4British Journal of Clinical Pharmacology · 2026 · Jonas Hallén, Sylvia Vetrhus, Margrethe Sørgaard et al.